Antimicrobial Activity of Aquipseudomonas alcaligenes Strain
https://doi.org/10.37489/02352990-2025-70-7-8-4-9
EDN: PVZQZO
Abstract
Background. The search for new effective antibiotics is one of the main tasks in the field of medicine, which is due to the spread of antibiotic-resistant pathogens that are not amenable to traditional chemotherapy.
The aim of the study was the search for a microorganism that could potentially produce an antibiotic exhibiting antimicrobial activity against pathogenic bacteria with multiple drug resistance.
The object of the study was a bacterium isolated from a freshwater indoor aquarium, identified as Aquipseudomonas alcaligenes and deposited in the collection of NIINA under the number INA 01568.
Materials and methods. For the surface cultivation of A. alcaligenes, bacterial and fungal strains, universal medium No. 2 Gause was used. Submerged cultivation was carried out in 18 nutrient media of different compositions. An agar diffusion method was used to determine the antimicrobial activity. Thirteen collection test strains of bacteria and fungi were used as test strains. Species identification was carried out by morphological features and the 16S rRNA gene.
Results. When cultured under submerged conditions on 2 media out of 18, the A. alcaligenes INA 01568 strain demonstrated antimicrobial activity against 6 test strains, including bacteria from the ESKAPE group, namely MRSA, Pseudomonas aeruginosa, as well as the vancomycin-resistant strain Leuconostoc mesenteroides; activity against these strains has been described for the first time. Activity against fungi was not detected.
Conclusion. The A. alcaligenes strain INA 01568 is promising for chemical research.
Keywords
About the Authors
I. A. MalanichevaRussian Federation
Irina A. Malanicheva — Senior Researcher worker, Sector for Searching for Natural Compounds that Overcome Bacterial Resistance.
Moscow
Competing Interests:
The authors declare no conflict of interest
E. V. Khramtsova
Russian Federation
Ekaterina V. Khramtsova — Junior Researcher, Sector for Searching for Natural Compounds that Overcome Bacterial Resistance.
Moscow
Competing Interests:
The authors declare no conflict of interest
M. O. Makarova
Russian Federation
Marina O. Makarova — Engineer, Laboratory of Mutagenesis and Selection of Biologically Active Substance Producers.
Moscow
Competing Interests:
The authors declare no conflict of interest
O. V. Efremenkova
Russian Federation
Olga V. Efremenkova — Ph. D. in Biology, Head of the Sector, Sector for Searching for Natural Compounds that Overcome Bacterial Resistance.
Moscow
Competing Interests:
The authors declare no conflict of interest
References
1. WHO. Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2020. Geneva: World Health Organization; 25 May 2020.
2. WHO Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024.
3. Kandyba A. L., Khramtsova E. V., Vasilyeva B. F., Boykova Ju. V., Glukhova A. A., Efimenko T. A., Efremenkova O. V. Antimicrobial activity of microorganisms isolated from the soil of the tropical desert of the Sinai Peninsula. Antibiotiki i Khimioter = Antibiotics and Chemotherapy. 2024; 69 (7–8): 9–16. doi: https://doi.org/10.37489/0235-2990-2024-697-8-9-16. (in Russian)]
4. Sanya D. R. A. Onésim D., Vizzarro G., Jacquier N. Recent advances in therapeutic targets identification and development of treatment strategies towards Pseudomonas aeruginosa infections. BMC Microbiol. 2023; 23 (1): 86. doi: 10.1186/s12866-023-02832-x.
5. Mlynarczyk-Bonikowska B., Kowalewski C., Krolak-Ulinska A., Marusza W. Molecular mechanisms of drug resistance in Staphylococcus aureus. Internat J Mol Sci. 2022; 23 (15): 8088. doi: 10.3390/ijms23158088.
6. Ajmi N., Tasc G., Saticiogl I. B., Duman M. Pangenome analysis of Aquipseudomonas alcaligenes 67P: insights into ecological distribution, environmental adaptation, and metabolic versatility. Total Environment Microbiology. 2025: 100010. doi: https://doi.org/10.1016/j.temicr.2025.100010.
7. Iwata K., Akiba T. Studies on the in vitro antibacterial activity of leucomycin. J Antibiot. Series A. 1962; 15 (6): 258–265. doi: 10.2174/1874467213666200518094445.
8. Sidorova T. M., Asaturova A. M., Allahverdyan V. V. Osobennosti antagonizma bakterij roda Bacillus po otnosheniyu k toksinogennym gribam Fusarium pri zashchite rastenij ot bolezni i kontaminacii mikotoksinami (obzor). Yug Rossii: Ekologiya, Razvitie. 2021; 4 (61): 86–103. doi: https://doi.org/10.18470/1992-1098-2021-4-86-103.
9. Vanittanakom N., Loeffler W., Koch U., Jung G. Fengycin-a novel antifungal lipopeptide antibiotic produced by Bacillus subtilis F-29-3. J Antibiot (Tokyo). 1986; 39 (7): 888–901. doi: 10.7164/antibiotics.39.888.
10. Mawji E.,Gledhill M., Milton J. A., Tarran G. A., Ussher S., Thompson A., Wolff G. A., Worsfold P. J., Achterberg E. P. Hydroxamate siderophores: occurrence and importance in the Atlantic Ocean. Environ Sci Technol. 2008; 42 (23): 8675–8680. doi: 10.1021/es801884r.
11. Prabhakar P. K. Bacterial siderophores and their potential applications: a review. Curr Mol Pharmacol. 2020; 13 (4): 295–305. doi: 10.11554/antibioticsa.15.6_258.
12. Barker W. R., Callaghan C., Hill L., Noble D., Acred P., Harper P. B., Sowa M. A., Fletton R. A. G1549, a new cyclic hydroxamic acid antibiotic, isolated from culture broth of Pseudomonas alcaligenes. J Antibiot (Tokyo). 1979; 32 (11): 1096–1103. doi: 10.7164/antibiotics.32.1096.
Review
For citations:
Malanicheva IA, Khramtsova EV, Makarova MO, Efremenkova OV. Antimicrobial Activity of Aquipseudomonas alcaligenes Strain. Antibiotiki i Khimioterapiya = Antibiotics and Chemotherapy. 2025;70(7-8):4-9. (In Russ.) https://doi.org/10.37489/02352990-2025-70-7-8-4-9. EDN: PVZQZO















































